Taprenepag
2-[3-[[(4-pyrazol-1-ylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]phenoxy]acetic acid
Molecular Identity
Taprenepag
2-[3-[[(4-pyrazol-1-ylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]phenoxy]acetic acid
PubChem CID: 18376177
2D Structure
Properties
C24H22N4O5S
Molecular Formula
478.50
Molecular Weight
g/mol
478.1311
Exact Mass
Da
2.5
XLogP
Drug-like (Lipinski: < 5)
123
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
8
H-Bond Acceptors
753
Complexity
SMILES
Canonical SMILES
SMILES: C1=CC(=CC(=C1)OCC(=O)O)CN(CC2=CC=C(C=C2)N3C=CC=N3)S(=O)(=O)C4=CN=CC=C4Isomeric SMILES
SMILES: C1=CC(=CC(=C1)OCC(=O)O)CN(CC2=CC=C(C=C2)N3C=CC=N3)S(=O)(=O)C4=CN=CC=C4Synonyms(20)
Taprenepag752187-80-7CP 544326CP-544326CP5443262-[3-[[(4-pyrazol-1-ylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]phenoxy]acetic acid9CD894KUMJPF04217329PF 04217329DTXSID002261872-(3-((N-((4-(1H-PYRAZOL-1-YL)PHENYL)METHYL)PYRIDINE-3-SULFONAMIDO)METHYL)PHENOXY)ACETIC ACID2-(3-(((4-pyrazol-1-ylphenyl)methyl-pyridin-3-ylsulfonylamino)methyl)phenoxy)acetic acidRefChem:932569DTXCID00148678PF-04217329
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Taprenepag
Loading drug network...